MENU Success for Terry Open to New Treatment Three years after his treatment, Terry remains free of pain and full of energy. WATCH VIDEO BD and BARD ANNOUNCE ACQUISITION AGREEMENT Learn More Advancing Lives and the Delivery of Health Care™ For more than a century, C. R. Bard, Inc. has been at the forefront of developing innovative medical devices that solve the challenges of healthcare professionals and patients. Watch our video to learn how Bard is pursuing technological innovations that offer superior clinical benefits while helping to reduce overall health care costs. Value-Based Healthcare In an ever-changing healthcare landscape, evidence-based decision making has become essential. With a focus on cost-effective, positive outcomes, Bard offers clinical and economic data to communicate the value of Bard products and services that consistently support the Cost, Quality, and Outcome continuum. LEARN MORE Patients & Caregivers Making a Difference in Peoples Lives If you or a loved one has been diagnosed with a health condition, we’re here to help. In this section, learn more about the condition, the products and procedures used to treat it, and resources for more information and support. Breast Cancer Cancer End-Stage Renal Disease Hernia Peripheral Arterial Disease Venous Disease Healthcare Professionals Innovation at the Heart of Health Care With our rich history of quality products and services, Bard is committed to providing our customers with the information and tools needed for you to be successful in your role in healthcare. Products Clinical Training & Education Value-Based Healthcare Solutions Healthcare Business Solutions Customer Support View All HIGHLIGHTS FROM BARD Bard Shareholders Approve Proposed Merger With Becton, Dickinson AUGUST 08, 2017 MURRAY HILL, N.J. and FRANKLIN LAKES, N.J., Aug. 8, 2017 /PRNewswire/ -- C. R. Bard, Inc. (NYSE: BCR) ("Bard") and Becton, Dickinson and Company (NYSE: BDX) ("BD") today announced the results of... Read More Bard Announces Second Quarter Results JULY 27, 2017 MURRAY HILL, N.J.--(BUSINESS WIRE)--Jul. 27, 2017-- C. R. Bard, Inc. (NYSE:BCR) today reported 2017 second quarter financial results. Second quarter 2017 net sales were $979.7 million,... Read More Bard Declares Quarterly Dividend JUNE 14, 2017 MURRAY HILL, N.J.--(BUSINESS WIRE)--Jun. 14, 2017-- The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today declared a regular quarterly dividend of 26 cents per share on Bard's... Read More MORE CAREERS Achieve more, grow more, be more™ View Careers at C. R. Bard, Inc. Have a great idea for a new product? CHECK OUT OUR REGIONAL WEBSITES Transformation 'Bard.Transformations.GlobalDirectoryLink-bottom' not found. Criqui MH, Aboyans, V. Epidemiology of peripheral artery disease. Circulation Research. 2015;116:1509-1526, originally published April 23, 2015. Fowkes, F Gerald R et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. The Lancet , Volume 382 , Issue 9901 , 1329 - 1340. Stock Quote BCR: 318.66 Change: 0.00 Volume Traded: 0 As of 8/24/2017 9:04:49 AM (20 Minutes Delay Minimum) See Details > Advancing Lives and the Delivery of Health Care™ CORP 17-23.02 Copyright © 2017 C. R. Bard, Inc. All Rights Reserved. Terms of Use | Privacy Policy